160 related articles for article (PubMed ID: 26714379)
1. Can Plasma Hyaluronan and Hyaluronidase Be Used As Markers of the Endothelial Glycocalyx State in Patients with Kidney Disease?
Vlahu CA; Krediet RT
Adv Perit Dial; 2015; 31():3-6. PubMed ID: 26714379
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases.
Dogné S; Flamion B; Caron N
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1427-1439. PubMed ID: 29880486
[TBL] [Abstract][Full Text] [Related]
3. Endothelial Glycocalyx Impairment in Disease: Focus on Hyaluronan Shedding.
Dogné S; Flamion B
Am J Pathol; 2020 Apr; 190(4):768-780. PubMed ID: 32035885
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover.
Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Flamion B; Caron N
Acta Histochem; 2015 Jan; 117(1):83-91. PubMed ID: 25468725
[TBL] [Abstract][Full Text] [Related]
5. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview.
Girish KS; Kemparaju K
Life Sci; 2007 May; 80(21):1921-43. PubMed ID: 17408700
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronidase 1 Deficiency Preserves Endothelial Function and Glycocalyx Integrity in Early Streptozotocin-Induced Diabetes.
Dogné S; Rath G; Jouret F; Caron N; Dessy C; Flamion B
Diabetes; 2016 Sep; 65(9):2742-53. PubMed ID: 27246914
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Glycocalyx Hyaluronan: Regulation and Role in Prevention of Diabetic Complications.
Wang G; Tiemeier GL; van den Berg BM; Rabelink TJ
Am J Pathol; 2020 Apr; 190(4):781-790. PubMed ID: 32035886
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction.
Queisser KA; Mellema RA; Middleton EA; Portier I; Manne BK; Denorme F; Beswick EJ; Rondina MT; Campbell RA; Petrey AC
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34314391
[TBL] [Abstract][Full Text] [Related]
9. Targeting hyaluronan of the endothelial glycocalyx for therapeutic intervention.
Wheeler-Jones CP; Farrar CE; Pitsillides AA
Curr Opin Investig Drugs; 2010 Sep; 11(9):997-1006. PubMed ID: 20730694
[TBL] [Abstract][Full Text] [Related]
10. Microrheology of hyaluronan solutions: implications for the endothelial glycocalyx.
Nijenhuis N; Mizuno D; Schmidt CF; Vink H; Spaan JA
Biomacromolecules; 2008 Sep; 9(9):2390-8. PubMed ID: 18700796
[TBL] [Abstract][Full Text] [Related]
11. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma.
Neudecker BA; Stern R; Connolly MK
Br J Dermatol; 2004 Mar; 150(3):469-76. PubMed ID: 15030329
[TBL] [Abstract][Full Text] [Related]
12. A role for the extracellular matrix component hyaluronan in kidney dysfunction during ACE-inhibitor fetopathy.
Hansell P; Palm F
Acta Physiol (Oxf); 2015 Apr; 213(4):795-804. PubMed ID: 25600777
[TBL] [Abstract][Full Text] [Related]
13. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
Udabage L; Brownlee GR; Nilsson SK; Brown TJ
Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700
[TBL] [Abstract][Full Text] [Related]
14. Role of endothelial hyaluronan in peritoneal membrane transport and disease conditions during peritoneal dialysis.
Kamiya K; Hatayama N; Tawada M; Asai A; Yamauchi M; Kinashi H; Kunoki S; Yamaguchi M; Mizuno M; Suzuki Y; Banshodani M; Ishimoto T; Naito M; Kawanishi H; Ito Y
Sci Rep; 2024 Mar; 14(1):7412. PubMed ID: 38548914
[TBL] [Abstract][Full Text] [Related]
15. PRELIMINARY HIGH PERFORMANCE CAPILLARY ELECTROPHORESIS (HPCE) STUDIES OF ENZYMATIC DEGRADATION OF HYALURONIC ACID BY HYALURONIDASE IN THE PRESENCE OF POLYVALENT METAL IONS.
Urbaniak B; Plewa S; Kokot ZJ
Acta Pol Pharm; 2017 Jan; 74(1):41-51. PubMed ID: 29474760
[TBL] [Abstract][Full Text] [Related]
16. Early changes in lung tissue hyaluronan (hyaluronic acid) and hyaluronidase in bleomycin-induced alveolitis in hamsters.
Bray BA; Sampson PM; Osman M; Giandomenico A; Turino GM
Am Rev Respir Dis; 1991 Feb; 143(2):284-8. PubMed ID: 1703735
[TBL] [Abstract][Full Text] [Related]
17. Effects of peritoneal hyaluronidase treatment on transperitoneal solute and fluid transport in the rat.
Carlsson O; Rosengren BI; Rippe B
Acta Physiol Scand; 2000 Mar; 168(3):371-6. PubMed ID: 10712574
[TBL] [Abstract][Full Text] [Related]
18. Deficiency in mouse hyaluronidase 2: a new mechanism of chronic thrombotic microangiopathy.
Onclinx C; Dogne S; Jadin L; Andris F; Grandfils C; Jouret F; Mullier F; Flamion B
Haematologica; 2015 Aug; 100(8):1023-30. PubMed ID: 25934767
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation.
Atmuri V; Martin DC; Hemming R; Gutsol A; Byers S; Sahebjam S; Thliveris JA; Mort JS; Carmona E; Anderson JE; Dakshinamurti S; Triggs-Raine B
Matrix Biol; 2008 Oct; 27(8):653-60. PubMed ID: 18762256
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and fragmentation of hyaluronan in renal ischaemia.
Declèves AE; Caron N; Voisin V; Legrand A; Bouby N; Kultti A; Tammi MI; Flamion B
Nephrol Dial Transplant; 2012 Oct; 27(10):3771-81. PubMed ID: 22529164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
